Cancer Institute of New Jersey (CINJ), Lung Cancer/Thoracic Program

Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Lung Cancer/Thoracic Program is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Small Cell Lung Carcinoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Carboplatin Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2004 2015

Chemoprevention
Research Personnel
Clinical Trials
Guideline Adherence
Synthetic Vaccines

Research Output 1974 2019

Exons
Mutation
Lung Neoplasms
N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide
HM781-36B

A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer

Goel, S., Swami, U., Kumar, K., Dittrich, C., Reyderman, L., Jain, M., Aisner, J., Song, J. & Petrylak, D. P., Sep 1 2019, In : Cancer chemotherapy and pharmacology. 84, 3, p. 567-578 12 p.

Research output: Contribution to journalArticle

eribulin
Carboplatin
Non-Small Cell Lung Carcinoma
Labels
Tumors

A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors

Stein, M., Goodin, S., Gounder, M., Gibbon, D., Moss, R., Portal, D., Lindquist, D., Zhao, Y., Takebe, N., Tan, A., Aisner, J., Lin, H., Ready, N. & Mehnert, J., Jan 1 2019, (Accepted/In press) In : Investigational New Drugs.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Neoplasms
Area Under Curve
Prostate